Find the latest clinical trials by condition, location & phase
Browse and search for drug information and related clinical trials
Explore a comprehensive list of organizations, including their profiles and details.
Latest updates on clinical trials, pharmaceuticals, and healthcare companies
Stay informed with timely notifications on clinical trials and research advancements.
No overview information available.
No background information available.
No indication information available.
No associated conditions information available.
Therini Bio has raised $39 million in Series A extension financing, bringing total Series A funding to $75 million with support from new investors Angelini Ventures and Apollo Health Ventures.
Therini Bio's novel monoclonal antibody THN391, targeting fibrin-driven neuroinflammation, demonstrated positive safety and tolerability results in Phase 1a trials with healthy volunteers.